Af­ter three decades and a sur­prise re­jec­tion, first treat­ment for ba­bies born with­out a thy­mus se­cures FDA ap­proval

Sum­i­to­vant Bio­phar­ma’s sub­sidiary En­zy­vant late Fri­day won ap­proval for its first treat­ment, which is al­so the first promis­ing treat­ment for ba­bies with­out a thy­mus, an …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER